4 recipient SNPs should be viewed as a single predictor of cGVHD. Notably, this region encompasses exon 3 and flanking regions, prompting us to further study a potential functional role of these SNPs.
SNPs that result in increased BAFF production are potentially relevant for cGVHD pathophysiology, since excess BAFF has been significantly associated with disease status. 3, 4 BAFF SNPs associated with autoimmune diseases and lymphomas have been reported in the promoter region and demonstrated to be functional. [5] [6] [7] [8] We noted that all 20 SNPs tested by Clark et al 1 were within introns 2 through 5, but none were in the promoter. LD between a known functional promoter SNP, rs9514828, and these 4 SNPs was very low (r 2 ranged from 0.03-0.05). We therefore considered whether 1 of these SNPs might affect splicing as a potential mechanism leading to cGVHD, particularly because alternative splicing of exon 3 results in the only known functional BAFF isoform, ⌬BAFF. 9 Using the Human Splicing Finder (http://www.umd.be/ HSF/), 10 we located the splice sites flanking exon 3. Only 1 SNP, rs12428930, was Ͻ 1000 bp from an intron/exon boundary, but not within a predicted splice site. According to the dbSNP build 135 database (http://www.ncbi.nlm.nih.gov/SNP/), there are no known SNPs located within 200 bp of the exon/intron boundaries of exon 3; however, the SNPs identified by Clark et al flank exon 3, suggesting they may be markers of a functional SNP that affects alternative splicing, potentially leading to ⌬BAFF production. 
